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1. Introduction 
It has been shown in many laboratories [l-3] 
that Factor X is resolved into two protein peaks on 
chromatography on DEAE-Sephadex. So far no 
chemical differences in the chemical composition of 
these two forms of the protein have been described 
which might account for this difference in behaviour 
on chromatography. Although Jackson [4] has 
shown small differences in the sialic acid and hexose 
content of the two forms of Factor X these differences 
have not been observed by others [2,5]. 
On the other hand Fujikawa et al. [2] and.Esnouf 
et al. [3] have shown that there is a difference in the 
specific activity of Factor Xi and Factor X2, Factor 
X1 having 86% [2] and 70% [3] the activity of 
Factor X2. 
The simplest interpretation of the difference in the 
chromatographic behaviour of the two forms of 
Factor X is that Factor X2, which is eluted after 
Factor X1, has a higher negative charge than Factor 
X1 and is retained on the column longer. Against his 
idea is the observation that Factor X1 and X2 are not 
resolved by electrophoresis on polyacrylamide gels 
[2,3,6], but this objection could be invalid because 
normal and abnormal prothrombin are also not 
resolved by this technique [7]. Normal prothrombin 
has the more negative charges than abnormal pro- 
thrombin [8,9] , which arise from the carboxylation 
of the y carbon of ten glutamic acid residues in the 
N-terminal portion of normal prothrombin. Recently 
this 1,3,3’-tricarboxy amino propane (Gla) residue 
has been indirectly identified in the N-terminal 
portion of the light chain of Factor X [lo] . In view 
of these observations we have analysed alkaline hydro- 
lysates of the light chains of Factor X1 and Xz to test 
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whether the difference in the chromatographic 
behaviour of these two forms of the protein could be 
accounted for by a difference in their Gla content. 
2. Materials and methods 
2.1. Beparation of Factors X1 and X2 
Factor X was prepared as described by Esnouf et 
al. [3], except hat all buffers contained 1 mM 
benzamidine and X1 and X2 were further separated 
by rechromatography onDEAE-Sephadex A-50 
(Pharmacia Fine Chemicals Ltd., London) with 
200-400 mM gradient of sodium citrate-citric acid 
buffer, pH 6.8, containing 1 mM benzamidine. 
The two cows treated with vitamin K received 
10 mg/day intramuscularly for ten days prior to the 
collection of the blood. 
2.2. eeparation of light chains 
The light chains were obtained by two different 
procedures (a) The separated Factor X1 and Xz were 
reduced, carboxy-methylated and the light chains 
recovered by gel filtration. (b) Factors X1 and Xz 
were pooled, reduced and the mixed light chains, 
obtained by gel filtration, were separated by ion 
exchange chromatography. 
2.2.1. Route A 
The pools containing Factor Xr (40 mg) and XZ 
(20 mg) were separately concentrated to about 5 mg 
protein/ml and dialysed overnight into 6 M guanidine 
hydrochloride buffered with 0.2 M Tris-HCl buffer, 
pH 8.0. The solution was then made 5% with respect 
to 2-mercaptoethanol and incubated at 37’C for 1 h 
and the reduced protein carboxy-methylated after 
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adding iodoacetic acid to a final concentration of 0.i 
M; the pH was maintained at 8.0 by the addition of 
1 .O M Tris. After 15 min the excess iodoacetic was 
eliminated by the further addition of 2-mercapto- 
ethanol. The carboxy-methylated heavy and light 
chains were separated by gel filtration on a column 
of LKB (LKB Ltd., Croydon, Surrey) Ultrogel AcA 
44 (2.5 X 80 cm) eluted with 0.1 M NH,,HCOs. The 
fractions containing the light chains of X1 and Xz 
were pooled and taken to dryness on a rotary eva- 
porator. 
2.2.2. Route B 
A pool containing both Factor X1 and Xz was 
concentrated to approximately 60 mg protein/ml 
and made 4 M with respect to guanidine hydrochloride. 
After incubation at 37°C for 30 min with a 3-fold 
molar excess of dithiothreitol, the mixed (XI + Xs) 
heavy and light chains were separated on a column of 
LKB Ultrogel AcA 44 (2.5 X 100 cm) eluted with 
0.1 M sodium citrate buffer pH 6.9 containing 1 mM 
dithiothreitol. The mixed (XI t X,) light chains were 
concentrated and separated from each other by 
chromatography on DEAE-Sephadex A-50 (1.5 X 20 
cm) eluted with a citrate gradient containing 1 mM 
dithiothreitol, from 0.2-0.6 M sodium citrate, 
pH 6.9. Samples of X1 and X2 light chains were taken 
for alkaline hydrolysis. 
3. Other methods 
Electrophoresis was performed by the method of 
Weber and Osborn [ 1 l] . Factor X was assayed as 
described by Prowse et al. [ 121. Amino acid analyses 
were carried out using Aminex A5 and A4 resins (Bio- 
Rad Laboratories, Bromley, Kent) by the procedure 
of Moore and Stein [ 131. Samples were either 
hydrolysed in 6 M HCl in sealed glass tubes or 15% 
NaOH in polypropylene tubes, at 1 10°C, for 18 h 
after flushing with nitrogen. Norleucine was added to 
each sample as an internal standard. After hydrolysis 
HCl was removed by rotary evaporation and the NaOH 
by ion exchange on a Dowex 50 W X 8 column in 1 M 
NHJOH, and the sample dried by rotary evaporation. 
Alkaline hydrolysis gave a 90% recovery of GLA from 
prothrombin. y_Carboxyglutamic acid was synthesised 
by the method of Fernlund et al. [9]. 
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4. Results 
SDS gel electrophoresis of the light chains obtained 
by either route A or B showed that the separation 
from the heavy chain had been complete. Two routes 
for the preparation of the light chains were employed, 
firstly to check that none of the techniques employed 
resulted in the decarboxylation of Gla residues and 
secondly to test whether the light chains of X1 and 
Xz could be resolved by ion exchange chromatography. 
Taking the last point first, fig.1 shows that the light 
chains are readily separated by chromatography on 
DEAE-Sephadex and that the separation achieved is 
substantially better than the separation of Factor X1 
from Factor Xs , which would support the hypothesis 
that the difference in the chromatographic behaviour 
of the two forms of Factor X is caused by the hetero- 
geneity of the light chains. Alkaline hydrolysis showed 
that pool 1 (fig.1) was the light chain of Factor X1. 
Amino acid analysis of the light chains after acid 
hydrolysis shows no differences in their composition 
Fig.1. The separation of the light chains of Factor X, and 
Factor X, on a column of DEAE-Sephadex A-50 (1.5 X 20 
cm). The protein was eluted at a flow rate of 40 ml/h with a 
linear gradient of 0.2-0.6 M sodium citrate pH 6.9 containing 
1 mM dithiothreitol. The protein was pooled as indicated. 
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Table 1 
Amino acid composition of the light chains of 
Factor X, and X, (moles per 17 000 g) 
Acid hydrolysates 
XI X, X? 
- 
Lys 6.8 6.6 7 
His 2.9 2.8 3 
Arg 7.1 7.0 8 
Asp 13.4 13.2 14 
Thr 5.8 6.2 6 
Ser 8.6 8.6 11 
GlU 23.6 23.7 27 
GAY 13.6 14.0 14 
Ala 6.3 6.3 6 
Val 4.4 6.1 5 
Be 1.7 2.9 2 
I&u 6.5 7.3 7 
Tyr 1.9 2.7 3 
Phe 6.3 5.4 8 
Alkaline hydrolysate 
XI X, 
I_____-- 
Route A Route B Route A Route B 
Glll 15.8 14.9 10.9 
Gla 6.8 8.1 12.8 
a Values taken from Enfield et al. [ 141. 
10.9 
13.3 
(table 1) a result which confirms the findings of others 
[2,4] . However analysis of the amino acids released 
by alkaline hydrolysis revealed aconsiderable differ- 
ence in the Glu and Gla content. Gla is not seen in 
acid hydrolysates because it is readily decarboxylated 
to Glu during the hydrolysis. Gla was identified in t$e 
alkaline hydrolysates by co-chromatography with an 
authentic sample of the amino acid, and was quantita- 
ted taking the ninhydrin colour value for glutamic acid. 
This was necessary because the colour value for the Gla 
standard ecreased on storage, probably due to spon- 
taneous cyclization to pyro y-carboxyglutamic a id. 
The results how (table 1) that while the sum of 
Gla and Glu residues obtained by alkaline hydrolysis 
is in good agreement with the number of Glu residues 
seen in acid hydrolysates; the Gla content of X, light 
chain is only 62% of XZ light chain which implies XZ 
has 5 more negative charges than X1, an observation 
that is consistent with the difference in the chromato- 
graphic behaviour of the two chains. 
It might be supposed that the reduced carboxyla- 
tion of X1 could be the result of a partial vitamin K 
deficiency in cattle. To test this two’cows were given 
intramuscular injections of 10 mg vitamin K per day 
for 10 days prior to the collection of the blood. In 
both cases the Factor X was recovered in two separate 
peaks, as in the untreated animals, also like the 
untreated cattle the specific activity of X1 was 64% 
that of X2. 
5. Discussion 
At present it is difficult to understand why these 
two forms of Factor X circulate in the plasma, and 
when assayed using Russell’s viper venom have a 
different specific activity. The possibility that the two 
forms of Factor X arise as an artefact of the initial 
purification process cannot be eliminated entirely. 
But the finding that the Glu:Gla ratio of X1 and XZ 
and the amounts of X1 and XZ are not altered by 
re-chromatography on DEAE-Sephadex would 
suggest that if these changes do take place during the 
preparation of Factor X they can only be associated 
with the blood collection or the adsorption on inso- 
luble barium salts. Since this last step is used for the 
separation of Gla containing peptides from enzymic 
digests of prothrombin [8,9] it would seem to be 
unlikely that the adventitious decarboxylation of
Factor X1 occurs at this step. Since it is unlikely that 
Factor X1 is decarboxylated during blood collection, 
it must be that X1 and XZ coexist in plasma. 
Hitherto the only other indication that Factor X1 
and XZ differed comes from measurements of the 
specific activity using Russell’s viper venom. In both 
instances [2,3] the less carboxylated Factor X1 has a 
lower specific activity than Factor X2. Recently 
incomplete carboxylation of prothrombin [121 has 
been implicated in causing areduction in the specific 
activity of that protein isolated from the blood of 
cattle during Warfarimtreatment, as calcium ions are 
required both for the activation of Factor X and for 
prothrombin it would not be unreasonable to suppose 
that reduced specific activity of the Factor X1, like 
abnormal prothrombin, arises from a slower rate of 
activation. 
The thirteen y-carboxyglutamic a id residues found 
for XZ are in close agreement with _the twelve modified 
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glutamic acid residues suggested by Enfield et al. [14] 
for X1 and X2. However these authors have not 
identified the y-carboxyglutamic acid residues as such, 
but have based their interpretations on the basis of 
poor yields at certain cycles of the sequenator, and 
on sequence homology with prothrombin. Howard 
and Nelsestuen [lo] have also concluded that the 
N-terminal portion of the light chain, prepared from 
a pool of X1 and XZ has fourteen y-carboxyglutamic 
acid residues. 
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